156 related articles for article (PubMed ID: 3766632)
21. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator.
Rosenberg P; Wingren S; Simonsen E; Stàl O; Risberg B; Nordenskjöld B
Gynecol Oncol; 1989 Oct; 35(1):50-4. PubMed ID: 2792902
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
[TBL] [Abstract][Full Text] [Related]
26. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
28. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
29. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
30. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
[TBL] [Abstract][Full Text] [Related]
31. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
33. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
Zaino RJ; Davis AT; Ohlsson-Wilhelm BM; Brunetto VL
Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
35. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma.
Chin JL; Pontes JE; Frankfurt OS
J Urol; 1985 Apr; 133(4):582-5. PubMed ID: 3981703
[TBL] [Abstract][Full Text] [Related]
37. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric DNA analysis of human endometrial carcinoma.
Tase T; Toki T; Oikawa N; Wada Y; Yajima A; Suzuki M
Tohoku J Exp Med; 1985 Aug; 146(4):429-37. PubMed ID: 4071538
[TBL] [Abstract][Full Text] [Related]
39. Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium.
Pradhan M; Abeler VM; Danielsen HE; Sandstad B; Tropé CG; Kristensen GB; Risberg BÅ
Ann Oncol; 2012 May; 23(5):1178-1184. PubMed ID: 21965471
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometric DNA ploidy analysis of feline mammary tumors.
Minke JM; Cornelisse CJ; Stolwijk JA; Kuipers-Dijkshoorn NJ; Rutteman GR; Misdorp W
Cancer Res; 1990 Jul; 50(13):4003-7. PubMed ID: 2354449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]